New England Professional Planning Group Inc. Viatris Inc Transaction History

New England Professional Planning Group Inc.

$202 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	BUY	$9.81 - $15.4 $58,604 - $91,999	5,974 New	5,974 $1.88 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $139,232 - $173,370	-10,735 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $15,777 - $21,524	-1,161 Reduced 9.76%	10,735 $146,000
Q4 2020 Jan 29, 2021	BUY	$14.3 - $18.74 $170,112 - $222,931	11,896 New	11,896 $217,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.73 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.14 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$775 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$769 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$599 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Professional Planning Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Professional Planning Group Inc. with notifications on news.

Account